Autologous Cell Therapy Global Market Report 2025

Global Autologous Cell Therapy Market Report 2025

Autologous Cell Therapy Global Market Report 2025 – By Therapy (Autologous Stem Cell Therapy, Autologous Cellular Immunotherapies), By Source (Bone Marrow, Epidermis, Mesenchymal Stem Cells, Hematopoietic Stem Cells, Chondrocytes, Other Sources), By Application (Cancer, Neurodegenerative Disorders, Cardiovascular Disorders, Autoimmune Disorders, Orthopedics, Wound Healing, Other Applications), By End User (Hospitals And Clinics, Ambulatory Centers, Academics And Research, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

Name: Autologous Cell Therapy Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Autologous Cell Therapy Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Autologous Cell Therapy Global Market Report 2025

Proud Members Of

Autologous Cell Therapy Market Definition

Autologous cell therapy refers to a type of cell therapy where a patient's cells are collected, processed, and then reintroduced into their own body for therapeutic purposes. It is often used in regenerative medicine to repair, replace, or restore damaged tissues or organs.

The main types of autologous cell therapy are autologous stem cell therapy and autologous cellular immunotherapies. Autologous stem cell therapy is a specific form of autologous cell therapy that utilizes stem cells derived from the patient's body for therapeutic purposes. The different sources include bone marrow, epidermis, mesenchymal stem cells, Hematopoietic stem cells, chondrocytes, and others, that are applied in cancer, neurodegenerative disorders, cardiovascular disorders, autoimmune disorders, orthopedics, wound healing, and others. It is used by hospitals and clinics, ambulatory centers, academics and research, and others.

Autologous Cell Therapy Market Segmentation

The autologous cell therapy market covered in this report is segmented –

1) By Therapy: Autologous Stem Cell Therapy, Autologous Cellular Immunotherapies

2) By Source: Bone Marrow, Epidermis, Mesenchymal Stem Cells, Hematopoietic Stem Cells, Chondrocytes, Other Sources

3) By Application: Cancer, Neurodegenerative Disorders, Cardiovascular Disorders, Autoimmune Disorders, Orthopedics, Wound Healing, Other Applications

4) By End User: Hospitals And Clinics, Ambulatory Centers, Academics And Research, Other End-Users

Subsegments:

1) By Autologous Stem Cell Therapy: Hematopoietic Stem Cell Transplantation, Mesenchymal Stem Cell Therapy, Adipose-Derived Stem Cell Therapy

2) By Autologous Cellular Immunotherapies: Chimeric Antigen Receptor (CAR) T-Cell Therapy, Tumor-Infiltrating Lymphocyte (TIL) Therapy, Dendritic Cell Therapy

Autologous Cell Therapy Market Size and growth rate 2025 to 2029: Graph

Autologous Cell Therapy Market Size 2025 And Growth Rate

The autologous cell therapy market size has grown rapidly in recent years. It will grow from$10.28 billion in 2024 to $12.19 billion in 2025 at a compound annual growth rate (CAGR) of 18.6%. The growth in the historic period can be attributed to advancements in regenerative medicine, increased prevalence of chronic diseases, enhanced understanding of cellular biology, patient preference for personalized medicine, clinical success and positive outcomes

Autologous Cell Therapy Market Growth Forecast

The autologous cell therapy market size is expected to see rapid growth in the next few years. It will grow to $23.33 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to continued growth in regenerative medicine, expanding applications across medical specialties, advancements in cell culture techniques, increasing investment and research initiatives, regulatory support, and standardization. Major trends in the forecast period include the development of automated manufacturing technologies, integration of biomarkers in treatment strategies, the emergence of point-of-care cell processing, expansion beyond hematopoietic stem cells, collaborations, and partnerships in the industry.

Book your 30 minutes free consultation with our research experts

Autologous Cell Therapy Market Driver: High Prevalence Of Chronic Diseases Drives Growth In Autologous Cell Therapy Market

The high prevalence of chronic diseases is expected to drive the growth of autologous cell therapy. Chronic disease is a condition or illness that lasts more than a year and requires ongoing medical treatment. Autologous cell therapy offers a promising approach for treating and managing these conditions that uses an individual's cells, which are cultivated and enlarged outside the body before being reintroduced into the donor. For instance, in January 2023, according to the National Library of Medicine, a US-based agency, the number of people in the US aged 50 and older who have at least 1 chronic condition would increase to 142.66 million by 2050. Thus, the high prevalence of chronic diseases is driving the growth of the autologous cell therapy market.

Autologous Cell Therapy Market Driver: Growing Aging Population Propels Growth In Autologous Cell Therapy Market

An increase in the aging population is expected to propel the growth of the autologous cell therapy market going forward. Aging population refers to the increasing median age in a population due to declining fertility rates and rising life expectancy. The aging population can benefit from autologous cell therapies as these treatments offer the potential for targeted and personalized interventions. For instance, in AugustJuly 20242, according to the the ARC Center of Excellence in Population Ageing ResearchOffice of National Statistics, a UK-based producer of official statistics, in 2022, the UK had approximately 12.7 million people aged 65 and over, accounting for 19% of the total population. Projections suggest that by 2072, this number could increase to 22.1 million, representing 27% of the population. collaboration of leading researchers in population aging, Australia’s population aged 65 and over is projected to grow to 6.66 million by 2041, from an estimated 4.31 million in 2021, which is an increase of 54%. For example, according to the ARC Center of Excellence in Population Ageing Research, a collaboration of leading researchers in population aging, Australia’s population aged 65 and over is projected to grow to 6.66 million by 2041, from an estimated 4.31 million in 2021, which is an increase of 54%. Therefore, the growing aging population is driving the growth of the autologous cell therapy market.

Global Autologous Cell Therapy Market Major Players

Major companies operating in the autologous cell therapy market include Bristol-Myers Squibb Company, Novartis AG, Vericel Corporation, Holostem Terapie Avanzate S.r.l., Pharmicell Co. Ltd., Opexa Therapeutics Inc., Tego Science AB, Brainstorm Cell Therapeutics Inc., Caladrius Biosciences Inc., Lineage Cell Therapeutics Inc., Castle Creek Biosciences Inc., Gilead Sciences Inc., Johnson & Johnson, CORESTEM Inc., Dendreon Pharmaceuticals LLC, Medipost Co. Ltd., PharmaJet Inc., Bioject Medical Technologies Inc., Medical International Technology Inc., INJEX Pharma AG, Lonza Group Ltd., Corning Incorporated, Takeda Pharmaceutical Company Limited, CSL Limited, AstraZeneca plc, Moderna Inc., Sinovac Biotech Ltd., Valneva SE, Bavarian Nordic A/S, Dynavax Technologies Corporation

Global Autologous Cell Therapy Market Trend: Technological Advancements Drive Efficiency In Autologous Cell Therapy Market

Technological advancement is a key trend in gaining popularity in the autologous cell therapy market. Major players in the market are automating the autologous cell therapy process to bring efficiency and sustain their businesses. For instance, in April 2022, Lonza, a Switzerland-based manufacturing company for the pharmaceutical, biotechnology, and nutrition sectors, developed the Cocoon Platform, a cutting-edge technology for manufacturing personalized cell and gene therapies. The Cocoon Platform utilizes an automated closed system, which minimizes the risk of contamination and ensures the sterility of the manufacturing process. As a result, it DRAMatically improves quality, lowers labor and material costs, and enables effective scaling-up of autologous T-cell products.

Global Autologous Cell Therapy Market Trend: Novartis Partners With Carisma Therapeutics For Her2-Targeted Car-M Cell Therapy Manufacturing

Major companies operating in the autologous cell therapy market are entering into strategic partnerships and collaborations to sustain their position in the market. Strategic partnerships are collaborative relationships formed between two or more organizations to achieve specific business objectives or goals. For instance, in March 2022, Novartis, a Switzerland-based pharmaceutical corporation, has signed an initial agreement with Carisma Therapeutics, a US-based clinical-stage biopharmaceutical company, to manufacture the HER 2 targeted CAR-M cell therapy, which is tested in initial trials for the treatment of solid tumors. The agreement involves the transfer of the Carisma Therapeutics manufacturing process to the Novartis Cell Therapy Site in the US, with clinical manufacturing planned to begin in 2023.

Autologous Cell Therapy Market Merger And Acquisition: Clade Therapeutics Expands Portfolio With Acquisition Of Gadeta B.V. For TCR-Based Immunotherapies

In October 2023, Clade Therapeutics a US-based cell therapy company acquired Gadeta B.V. for an undisclosed amount. The acquisition adds cell therapies such as innovative gamma/delta (g/d) T-cell receptor (TCR)-based immunotherapies for cancer patients, to Clade’s portfolio of offerings. Gadeta B.V. is a Netherlands-based cell therapy company.

Regional Analysis For The Global Autologous Cell Therapy Market

North America was the largest region in the autologous cell therapy market in 2024.Asia-pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the autologous cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the autologous cell therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Autologous Cell Therapy Market?

The autologous cell therapy market includes revenues earned by providing services in relation to cell collection, cell processing, cell expansion, or its modification. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Autologous Cell Therapy Industry?

The autologous cell therapy market research report is one of a series of new reports from The Business Research Company that provides autologous cell therapy market statistics, including autologous cell therapy industry global market size, regional shares, competitors with a autologous cell therapy market share, detailed autologous cell therapy market segments, market trends and opportunities, and any further data you may need to thrive in the autologous cell therapy industry. This autologous cell therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Autologous Cell Therapy Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$12.19 billion
Revenue Forecast In 2034	$23.33 billion
Growth Rate	CAGR of 17.6% from 2024 to 2033
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Therapy: Autologous Stem Cell Therapy, Autologous Cellular Immunotherapies 2) By Source: Bone Marrow, Epidermis, Mesenchymal Stem Cells, Hematopoietic Stem Cells, Chondrocytes, Other Sources 3) By Application: Cancer, Neurodegenerative Disorders, Cardiovascular Disorders, Autoimmune Disorders, Orthopedics, Wound Healing, Other Applications 4) By End User: Hospitals And Clinics, Ambulatory Centers, Academics And Research, Other End-Users Subsegments: 1) By Autologous Stem Cell Therapy: Hematopoietic Stem Cell Transplantation, Mesenchymal Stem Cell Therapy, Adipose-Derived Stem Cell Therapy 2) By Autologous Cellular Immunotherapies: Chimeric Antigen Receptor (CAR) T-Cell Therapy, Tumor-Infiltrating Lymphocyte (TIL) Therapy, Dendritic Cell Therapy
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Bristol-Myers Squibb Company, Novartis AG, Vericel Corporation, Holostem Terapie Avanzate S.r.l., Pharmicell Co. Ltd., Opexa Therapeutics Inc., Tego Science AB, Brainstorm Cell Therapeutics Inc., Caladrius Biosciences Inc., Lineage Cell Therapeutics Inc., Castle Creek Biosciences Inc., Gilead Sciences Inc., Johnson & Johnson, CORESTEM Inc., Dendreon Pharmaceuticals LLC, Medipost Co. Ltd., PharmaJet Inc., Bioject Medical Technologies Inc., Medical International Technology Inc., INJEX Pharma AG, Lonza Group Ltd., Corning Incorporated, Takeda Pharmaceutical Company Limited, CSL Limited, AstraZeneca plc, Moderna Inc., Sinovac Biotech Ltd., Valneva SE, Bavarian Nordic A/S, Dynavax Technologies Corporation
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Autologous Cell Therapy Market Characteristics

3. Autologous Cell Therapy Market Trends And Strategies

4. Autologous Cell Therapy Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Autologous Cell Therapy Growth Analysis And Strategic Analysis Framework

5.1. Global Autologous Cell Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Autologous Cell Therapy Market Growth Rate Analysis

5.4. Global Autologous Cell Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Autologous Cell Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Autologous Cell Therapy Total Addressable Market (TAM)

6. Autologous Cell Therapy Market Segmentation

6.1. Global Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Autologous Stem Cell Therapy

Autologous Cellular Immunotherapies

6.2. Global Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Bone Marrow

Epidermis

Mesenchymal Stem Cells

Hematopoietic Stem Cells

Chondrocytes

Other Sources

6.3. Global Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cancer

Neurodegenerative Disorders

Cardiovascular Disorders

Autoimmune Disorders

Orthopedics

Wound Healing

Other Applications

6.4. Global Autologous Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals And Clinics

Ambulatory Centers

Academics And Research

Other End-Users

6.5. Global Autologous Cell Therapy Market, Sub-Segmentation Of Autologous Stem Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hematopoietic Stem Cell Transplantation

Mesenchymal Stem Cell Therapy

Adipose-Derived Stem Cell Therapy

6.6. Global Autologous Cell Therapy Market, Sub-Segmentation Of Autologous Cellular Immunotherapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Chimeric Antigen Receptor (CAR) T-Cell Therapy

Tumor-Infiltrating Lymphocyte (TIL) Therapy

Dendritic Cell Therapy

7. Autologous Cell Therapy Market Regional And Country Analysis

7.1. Global Autologous Cell Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Autologous Cell Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Autologous Cell Therapy Market

8.1. Asia-Pacific Autologous Cell Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Autologous Cell Therapy Market

9.1. China Autologous Cell Therapy Market Overview

9.2. China Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Autologous Cell Therapy Market

10.1. India Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Autologous Cell Therapy Market

11.1. Japan Autologous Cell Therapy Market Overview

11.2. Japan Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Autologous Cell Therapy Market

12.1. Australia Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Autologous Cell Therapy Market

13.1. Indonesia Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Autologous Cell Therapy Market

14.1. South Korea Autologous Cell Therapy Market Overview

14.2. South Korea Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Autologous Cell Therapy Market

15.1. Western Europe Autologous Cell Therapy Market Overview

15.2. Western Europe Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Autologous Cell Therapy Market

16.1. UK Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Autologous Cell Therapy Market

17.1. Germany Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Autologous Cell Therapy Market

18.1. France Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Autologous Cell Therapy Market

19.1. Italy Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Autologous Cell Therapy Market

20.1. Spain Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Autologous Cell Therapy Market

21.1. Eastern Europe Autologous Cell Therapy Market Overview

21.2. Eastern Europe Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Autologous Cell Therapy Market

22.1. Russia Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Autologous Cell Therapy Market

23.1. North America Autologous Cell Therapy Market Overview

23.2. North America Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Autologous Cell Therapy Market

24.1. USA Autologous Cell Therapy Market Overview

24.2. USA Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Autologous Cell Therapy Market

25.1. Canada Autologous Cell Therapy Market Overview

25.2. Canada Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Autologous Cell Therapy Market

26.1. South America Autologous Cell Therapy Market Overview

26.2. South America Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Autologous Cell Therapy Market

27.1. Brazil Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Autologous Cell Therapy Market

28.1. Middle East Autologous Cell Therapy Market Overview

28.2. Middle East Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Autologous Cell Therapy Market

29.1. Africa Autologous Cell Therapy Market Overview

29.2. Africa Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Autologous Cell Therapy Market Competitive Landscape And Company Profiles

30.1. Autologous Cell Therapy Market Competitive Landscape

30.2. Autologous Cell Therapy Market Company Profiles

30.2.1. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Vericel Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Holostem Terapie Avanzate S.r.l. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Pharmicell Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Autologous Cell Therapy Market Other Major And Innovative Companies

31.1. Opexa Therapeutics Inc.

31.2. Tego Science AB

31.3. Brainstorm Cell Therapeutics Inc.

31.4. Caladrius Biosciences Inc.

31.5. Lineage Cell Therapeutics Inc.

31.6. Castle Creek Biosciences Inc.

31.7. Gilead Sciences Inc.

31.8. Johnson & Johnson

31.9. CORESTEM Inc.

31.10. Dendreon Pharmaceuticals LLC

31.11. Medipost Co. Ltd.

31.12. PharmaJet Inc.

31.13. Bioject Medical Technologies Inc.

31.14. Medical International Technology Inc.

31.15. INJEX Pharma AG

32. Global Autologous Cell Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Autologous Cell Therapy Market

34. Recent Developments In The Autologous Cell Therapy Market

35. Autologous Cell Therapy Market High Potential Countries, Segments and Strategies

35.1 Autologous Cell Therapy Market In 2029 - Countries Offering Most New Opportunities

35.2 Autologous Cell Therapy Market In 2029 - Segments Offering Most New Opportunities

35.3 Autologous Cell Therapy Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Autologous Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Autologous Cell Therapy Market, Sub-Segmentation Of Autologous Stem Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Autologous Cell Therapy Market, Sub-Segmentation Of Autologous Cellular Immunotherapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Autologous Cell Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Autologous Cell Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Bristol-Myers Squibb Company Financial Performance

Table 78: Novartis AG Financial Performance

Table 79: Vericel Corporation Financial Performance

Table 80: Holostem Terapie Avanzate S.r.l. Financial Performance

Table 81: Pharmicell Co. Ltd. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Autologous Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Autologous Cell Therapy Market, Sub-Segmentation Of Autologous Stem Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Autologous Cell Therapy Market, Sub-Segmentation Of Autologous Cellular Immunotherapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Autologous Cell Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Autologous Cell Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Bristol-Myers Squibb Company Financial Performance

Figure 78: Novartis AG Financial Performance

Figure 79: Vericel Corporation Financial Performance

Figure 80: Holostem Terapie Avanzate S.r.l. Financial Performance

Figure 81: Pharmicell Co. Ltd. Financial Performance

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

How Will The Nuclear Medicine Market Grow In 2022?

What Is The Pediatric Imaging Market Overview In 2022?

Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the medical aesthetics market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth

Cell Counting Global Market Report 2025 – By Consumables And Accessories (Media, Sera And Reagents, Assay Kits, Microplates, Accessories, Other Consumables), By Product (Spectrophotometers, Single-Mode Readers, Multi-Mode Readers, Cell Counters, Automated Cell Counters, Hemocytometers, Manual Cell Counters, Flow Cytometers, Hematology Analyzers), By Application (Research Applications, Clinical And Diagnostic Applications, Industrial Applications), By End-User (Hospitals And Diagnostic, Research Institutions, Pharmaceutical And Biotechnology Companies, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cellulose Esters and Ethers Global Market Report 2025 – By Product (Cellulose Acetate, Cellulose Nitrate, Carboxymethyl Cellulose, Methyl Cellulose, Ethyl Cellulose, Hydroxyethyl Cellulose, Hydroxypropyl Cellulose), By Process (Kraft Process, Sulphite Process), By End User Industry (Food And Beverages, Oil And Gas, Paper And Board, Paints And Adhesive, Detergents, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Live Cell Imaging Global Market Report 2025 – By Product (Equipment, Consumable, Software), By Technology (Time-Lapse Microscopy, Fluorescence Recovery After Photobleaching (FRAP), Fluorescence Resonance Energy Transfer (FRET), High Content Screening (HCS), Other Technologies), By Application (Cell Biology, Developmental Biology, Stem Cell and Drug Discovery, Other Applications), By End-User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Contract Research Organizations (CROs)) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Single-cell Analysis Global Market Report 2025 – By Product (Consumables, Instruments), By Workflow (Single-cell Isolation And Library Preparation, Downstream Analysis, Data Analysis), By Technique (Flow Cytometry, Next Generation Sequencing, Polymerase Chain Reaction (PCR), Microscopy, Mass Spectrometry, Other Techniques), By Application (Cancer, Immunology, Neurology, Stem cell, Non-invasive prenatal diagnosis, In-vitro fertilization, Other Applications), By End User (Academic and Research Laboratories, Biotechnology and Pharmaceutical Companies, Hospital and Diagnostic Laboratories) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Thin Film Solar Cell Global Market Report 2025 – By Type( Cadmium Telluride, Amorphous Thin-film Silicon, Copper Indium Gallium Selenide, Microcrystalline Tandem Cells, Thin-film Polycrystalline Silicon, Other Types), By Technology( On-Grid, Off-Grid), By Application( Residential, Commercial, Utility ) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Femtocell Global Market Report 2025 – By Type( 2G Femtocell, 3G Femtocell, 4G Femtocell,5G Femtocell), By Technology( IU-H, IMS/SIP), By End-User( Residential, Commercial, Public Space) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Stem Cell Manufacturing Global Market Report 2025 – By Product (Consumables, Instruments, Stem Cell Lines), By Application (Research Applications, Clinical Application, Cell and Tissue Banking Applications), By End User (Pharmaceutical And Biotechnology Companies, Academic Institutes, Research Laboratories And Contract Research Organizations, Hospitals And Surgical Centers, Cell And Tissue Banks, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Regenerated Cellulose Global Market Report 2025 – By Type( Fiber, Film), By Manufacturing Source( Viscose, Cuprammonium, N-ethyl-Morpholine-N-Oxide (NMMO)), By End Use Industry( Fabric, Automotive, Agriculture, Packaging, Other End Use Industries) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Autologous Cell Therapy market?

How will the Autologous Cell Therapy market drivers and restraints affect the market dynamics? What forces will shape the Autologous Cell Therapy industry going forward?

The Autologous Cell Therapy market major growth driver - High Prevalence Of Chronic Diseases Drives Growth In Autologous Cell Therapy Market. For further insights on the Autologous Cell Therapy market, request a sample here

What is the forecast market size or the forecast market value of the Autologous Cell Therapy market?

The Autologous Cell Therapy market size has grown strongly in recent years. The autologous cell therapy market size has grown rapidly in recent years. It will grow from$10.28 billion in 2024 to $12.19 billion in 2025 at a compound annual growth rate (CAGR) of 18.6%. The growth in the historic period can be attributed to advancements in regenerative medicine, increased prevalence of chronic diseases, enhanced understanding of cellular biology, patient preference for personalized medicine, clinical success and positive outcomes The autologous cell therapy market size is expected to see rapid growth in the next few years. It will grow to $23.33 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to continued growth in regenerative medicine, expanding applications across medical specialties, advancements in cell culture techniques, increasing investment and research initiatives, regulatory support, and standardization. Major trends in the forecast period include the development of automated manufacturing technologies, integration of biomarkers in treatment strategies, the emergence of point-of-care cell processing, expansion beyond hematopoietic stem cells, collaborations, and partnerships in the industry. For further insights on the Autologous Cell Therapy market, request a sample here

How is the Autologous Cell Therapy market segmented?

The autologous cell therapy market covered in this report is segmented –
1) By Therapy: Autologous Stem Cell Therapy, Autologous Cellular Immunotherapies
2) By Source: Bone Marrow, Epidermis, Mesenchymal Stem Cells, Hematopoietic Stem Cells, Chondrocytes, Other Sources
3) By Application: Cancer, Neurodegenerative Disorders, Cardiovascular Disorders, Autoimmune Disorders, Orthopedics, Wound Healing, Other Applications
4) By End User: Hospitals And Clinics, Ambulatory Centers, Academics And Research, Other End-Users Subsegments:
1) By Autologous Stem Cell Therapy: Hematopoietic Stem Cell Transplantation, Mesenchymal Stem Cell Therapy, Adipose-Derived Stem Cell Therapy
2) By Autologous Cellular Immunotherapies: Chimeric Antigen Receptor (CAR) T-Cell Therapy, Tumor-Infiltrating Lymphocyte (TIL) Therapy, Dendritic Cell Therapy For further insights on the Autologous Cell Therapy market, request a sample here

Which region has the largest share of the Autologous Cell Therapy market? What are the other regions covered in the report?

North America was the largest region in the autologous cell therapy market in 2024.Asia-pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the autologous cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the Autologous Cell Therapy market, request a sample here.

Who are the major players in the Autologous Cell Therapy market?

What are the key trends in the Autologous Cell Therapy market?

Major trends in the Autologous Cell Therapy market include Technological Advancements Drive Efficiency In Autologous Cell Therapy Market. For further insights on the Autologous Cell Therapy market, request a sample here.

What are the major opportunities in the Autologous Cell Therapy market? What are the strategies for the Autologous Cell Therapy market?

For detailed insights on the major opportunities and strategies in the Autologous Cell Therapy market, request a sample here.

How does the Autologous Cell Therapy market relate to the overall economy and other similar markets?

For detailed insights on Autologous Cell Therapy's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Autologous Cell Therapy industry?

For detailed insights on the mergers and acquisitions in the Autologous Cell Therapy industry, request a sample here.

What are the key dynamics influencing the Autologous Cell Therapy market growth? SWOT analysis of the Autologous Cell Therapy market.

For detailed insights on the key dynamics influencing the Autologous Cell Therapy market growth and SWOT analysis of the Autologous Cell Therapy industry, request a sample here.